blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0889053

EP0889053 - BK-RiV preparations for teatment of proliferative cellular disorders [Right-click to bookmark this link]
Former [1999/01]Uses of BK-RiV preparations, process for their production and proteins comprised therein
[2005/15]
StatusNo opposition filed within time limit
Status updated on  25.08.2006
Database last updated on 07.10.2024
Most recent event   Tooltip28.11.2008Lapse of the patent in a contracting state
New state(s): FR		published on 31.12.2008  [2009/01]
Applicant(s)For all designated states
Solisch, Peter, Dr.med.habil.
Am Rundling 7
17498 Riemserort / DE
[N/P]
Former [1999/01]For all designated states
Solisch, Peter, dr.med.habil.
Am Rundling 7
17498 Riemserort / DE
Inventor(s)01 / Solisch, Peter, Dr.med.habil.
Am Rundling 7
17498 Riemserort / DE
02 / Kalies, Kai-Uwe, Dr.
Saarbrücker Strasse 11
10405 Berlin / DE
03 / Bergmann, Steffi, Dr.
Auerstrasse 9
10247 Berlin / DE
[1999/01]
Representative(s)Ziebig, Marlene
Gulde Hengelhaupt
Ziebig & Schneider
Wallstrasse 58/59
DE-10179 Berlin / DE
[N/P]
Former [2008/43]Ziebig, Marlene
Gulde Hengelhaupt Ziebig & Schneider Patentanwälte Rechtsanwälte Wallstrasse 58/59
10179 Berlin / DE
Former [2002/15]Ziebig, Marlene, Dr. Dipl.-Chem.
Patentanwälte, Gulde Hengelhaupt Ziebig, Schützenstrasse 15-17
10117 Berlin / DE
Former [2002/09]Gulde, Klaus W., Dipl.-Chem.
Patentanwälte Gulde Hengelhaupt Ziebig Schützenstrasse 15-17
10117 Berlin / DE
Former [1999/01]Kolberg, Peter, Dr.
Genovevastrasse 6/8
12555 Berlin / DE
Application number, filing date98250225.422.06.1998
[1999/01]
Priority number, dateDE199712832327.06.1997         Original published format: DE 19728323
[1999/01]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP0889053
Date:07.01.1999
Language:DE
[1999/01]
Type: A3 Search report 
No.:EP0889053
Date:31.03.1999
[1999/13]
Type: B1 Patent specification 
No.:EP0889053
Date:19.10.2005
Language:DE
[2005/42]
Type: B8 Corrected title page of specification 
No.:EP0889053
Date:15.03.2006
[2006/11]
Search report(s)(Supplementary) European search report - dispatched on:EP12.02.1999
ClassificationIPC:C07K14/47, C07K1/14, A61K35/12, A61P17/06, A61P35/00, A61P29/00
[2005/15]
CPC:
A61K38/1709 (EP); A61P17/06 (EP); A61P29/00 (EP);
A61P35/00 (EP); C07K14/4721 (EP)
Former IPC [1999/01]C07K14/47, C07K1/14, A61K35/12
Designated contracting statesCH,   DE,   FR,   GB,   IT,   LI,   SE [1999/50]
Former [1999/01]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:BK-RiV-Präparate zur Behandlung von proliferativen Zellerkrankungen[2006/06]
English:BK-RiV preparations for teatment of proliferative cellular disorders[2005/15]
French:Préparations à base de BK-RiV pour le traitement de maladies prolifératives cellulaires[2005/15]
Former [1999/01]Verwendungen von BK-RiV-Präparaten, Verfahren zu deren Herstellung sowie darin enthaltene Proteine
Former [1999/01]Uses of BK-RiV preparations, process for their production and proteins comprised therein
Former [1999/01]Utilisations des préparations à base de BK-RiV, procédé de leur production, et les protéines contenues dans celles-ci
Examination procedure05.06.1999Examination requested  [1999/32]
02.04.2002Despatch of a communication from the examining division (Time limit: M06)
11.10.2002Reply to a communication from the examining division
07.05.2003Despatch of a communication from the examining division (Time limit: M06)
19.09.2003Reply to a communication from the examining division
18.03.2004Despatch of a communication from the examining division (Time limit: M04)
30.06.2004Reply to a communication from the examining division
18.03.2005Communication of intention to grant the patent
11.07.2005Fee for grant paid
11.07.2005Fee for publishing/printing paid
Opposition(s)20.07.2006No opposition filed within time limit [2006/39]
Fees paidRenewal fee
16.06.2000Renewal fee patent year 03
20.06.2001Renewal fee patent year 04
30.10.2002Renewal fee patent year 05
27.11.2003Renewal fee patent year 06
29.06.2004Renewal fee patent year 07
29.06.2005Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.06.200205   M06   Fee paid on   30.10.2002
30.06.200306   M06   Fee paid on   27.11.2003
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipFR19.10.2005
GB19.10.2005
IT19.10.2005
SE19.01.2006
[2009/01]
Former [2008/12]GB19.10.2005
IT19.10.2005
SE19.01.2006
Former [2007/17]GB19.10.2005
SE19.01.2006
Former [2006/27]SE19.01.2006
Documents cited:Search[DX]EP0702955  (SOLISCH PETER DR MED HABIL [DE], et al) [DX] 1,3 * siehe Spalte 1, Zeile 50 - Spalte 2, Zeile 28; Spalte 5, Zeilen 8-40; Ansprüche 1,3 *;
 [DX]DE9218127U  (SOLISCH PETER DR MED HABIL [DE], et al) [DX] 1,3 * siehe Seite 10, Zeile 11- Seite 12; Ansprüche 1-2 *;
 [DX]DE4238766  (SOLISCH PETER DR MED HABIL [DE], et al) [DX] 1-4 * siehe Spalte 1, Zeilen 30-66;Spalte 4, Zeilen 35-61; Anspruch 2; *;
 [X]DD156667  (SOLISCH PETER, et al) [X] 1,3,5 *siehe Seite 2, Zeilen 42-53; Seite 5, Zeilen 135-139; Anspruch *;
 [X]  - SOLISCH, "Zur Dignität einer bisher unbekannten Zellreaktion: "RiV". Eine Hypothese", ZENTRALBLATT FÜR PATHOLOGIE, (1992), vol. 138, no. 2, pages 136 - 140, XP002083610 [X] 1,3,5 * siehe insbesondere Seite 137, rechte Spalte "Biologische Wirkung" *
 [A]  - COX J C ET AL, "Adjuvants--a classification and review of their modes of action", VACCINE, (199702), vol. 15, no. 3, page 248-256, XP004094403 [A] 1-11,13,14 * siehe insbesondere Tabellen 1 und 2 *

DOI:   http://dx.doi.org/10.1016/S0264-410X(96)00183-1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.